메토트렉세이트 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "메토트렉세이트" in Korean language version.

Last modified: 15:45:15, 6 August 2026 (UTC)

Ref.Un. Ref.Website

Global rank Korean rank

337web.archive.org

1^st place

3227nih.gov

5^th place

4^th place

2924doi.org

2^nd place

3^rd place

221drugs.com

529^th place

121^st place

98semanticscholar.org

15^th place

11^th place

74archive.org

6^th place

5^th place

71medicinescomplete.com

low place

3,115^th place

51medscape.com

1,078^th place

351^st place

41adsabs.harvard.edu

14^th place

8^th place

22books.google.com

3^rd place

7^th place

21medicines.org.uk

4,892^nd place

1,205^th place

21versusarthritis.org

low place

11economist.com

331^st place

242^nd place

11who.int

213^th place

111^th place

11mshpriceguide.org

low place

2,198^th place

11clincalc.com

5,833^rd place

1,335^th place

11hu-berlin.de

3,223^rd place

2,866^th place

11nras.org.uk

low place

11mayoclinic.org

2,191^st place

636^th place

11nice.org.uk

4,081^st place

1,265^th place

11alphamedpress.org

low place

11psu.edu

299^th place

150^th place

adsabs.harvard.edu (Global: 14^th place; Korean: 8^th place)

Rajagopalan PT, Zhang Z, McCourt L, Dwyer M, Benkovic SJ, Hammes GG (October 2002). “Interaction of dihydrofolate reductase with methotrexate: ensemble and single-molecule kinetics”. 《Proceedings of the National Academy of Sciences of the United States of America》 99 (21): 13481–6. Bibcode:2002PNAS...9913481R. doi:10.1073/pnas.172501499. PMC 129699. PMID 12359872.

alphamedpress.org (Global: low place; Korean: low place)

theoncologist.alphamedpress.org

Goodsell DS (August 1999). “The molecular perspective: methotrexate”. 《The Oncologist》 4 (4): 340–1. doi:10.1634/theoncologist.4-4-340. PMID 10476546. 2012년 5월 24일에 원본 문서에서 보존된 문서. 2023년 10월 8일에 확인함.

archive.org (Global: 6^th place; Korean: 5^th place)

Joint Formulary Committee (2013). 《British National Formulary (BNF)》 65판. London, UK: Pharmaceutical Press. ISBN 978-0-85711-084-8.
Rajagopalan PT, Zhang Z, McCourt L, Dwyer M, Benkovic SJ, Hammes GG (October 2002). “Interaction of dihydrofolate reductase with methotrexate: ensemble and single-molecule kinetics”. 《Proceedings of the National Academy of Sciences of the United States of America》 99 (21): 13481–6. Bibcode:2002PNAS...9913481R. doi:10.1073/pnas.172501499. PMC 129699. PMID 12359872.
Hertz R, Li MC, Spencer DB (November 1956). “Effect of methotrexate therapy upon choriocarcinoma and chorioadenoma”. 《Proceedings of the Society for Experimental Biology and Medicine》 93 (2): 361–6. doi:10.3181/00379727-93-22757. PMID 13379512. S2CID 22939197.
Wright JC, Lyons MM, Walker DG, Golomb FM, Gumport SL, Medrek TJ (August 1964). “Observations on the Use of Cancer Chemotherapeutic Agents in Patients With Mycosis Fungoides”. 《Cancer》 17 (8): 1045–62. doi:10.1002/1097-0142(196408)17:8<1045::AID-CNCR2820170811>3.0.CO;2-S. PMID 14202592.

books.google.com (Global: 3^rd place; Korean: 7^th place)

Sneader, Walter (2005). 《Drug Discovery: A History》 (영어). John Wiley & Sons. 251쪽. ISBN 9780470015520. 2017년 2월 16일에 원본 문서에서 보존된 문서.
Bertino JR (2000). 〈Methotrexate: historical aspects〉. Cronstein BN, Bertino JR (편집). 《Methotrexate》. Basel: Birkhäuser. ISBN 978-3-7643-5959-1.

clincalc.com (Global: 5,833^rd place; Korean: 1,335^th place)

“The Top 300 of 2019”. 《clincalc.com》. 2018년 12월 22일에 확인함.

doi.org (Global: 2^nd place; Korean: 3^rd place)

dx.doi.org

Bannwarth, B; Labat, L; Moride, Y; Schaeverbeke, T (January 1994). “Methotrexate in rheumatoid arthritis. An update.”. 《Drugs》 47 (1): 25–50. doi:10.2165/00003495-199447010-00003. PMID 7510620.
Herfarth HH, Long MD, Isaacs KL (2012). “Methotrexate: underused and ignored?”. 《Digestive Diseases》 30 (Suppl 3): 112–8. doi:10.1159/000342735. PMC 4629813. PMID 23295701.
Boehm IB, Boehm GA, Bauer R (1998). “Management of cutaneous lupus erythematosus with low-dose methotrexate: indication for modulation of inflammatory mechanisms”. 《Rheumatol Int》 18 (2): 59–62. doi:10.1515/cclm.1993.31.10.667. PMID 9782534. S2CID 25311594.
Lopez-Olivo MA, Siddhanamatha HR, Shea B, Tugwell P, Wells GA, Suarez-Almazor ME (June 2014). “Methotrexate for treating rheumatoid arthritis”. 《The Cochrane Database of Systematic Reviews》 2014 (6): CD000957. doi:10.1002/14651858.CD000957.pub2. PMC 7047041. PMID 24916606.
Cronstein BN (June 2005). “Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis”. 《Pharmacological Reviews》 57 (2): 163–72. doi:10.1124/pr.57.2.3. PMID 15914465. S2CID 1643606.
American Rheumatoid Arthritis Guidelines (February 2002). “Guidelines for the management of rheumatoid arthritis: 2002 Update”. 《Arthritis and Rheumatism》 46 (2): 328–46. doi:10.1002/art.10148. PMID 11840435.
Colebatch AN, Marks JL, Edwards CJ (November 2011). “Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis)”. 《The Cochrane Database of Systematic Reviews》 (11): CD008872. doi:10.1002/14651858.CD008872.pub2. PMID 22071858.
Donahue KE, Schulman ER, Gartlehner G, Jonas BL, Coker-Schwimmer E, Patel SV 외 (October 2019). “Comparative Effectiveness of Combining MTX with Biologic Drug Therapy Versus Either MTX or Biologics Alone for Early Rheumatoid Arthritis in Adults: a Systematic Review and Network Meta-analysis”. 《Journal of General Internal Medicine》 34 (10): 2232–2245. doi:10.1007/s11606-019-05230-0. PMC 6816735. PMID 31388915.
Herfarth HH (2016년 1월 1일). “Methotrexate for Inflammatory Bowel Diseases - New Developments”. 《Digestive Diseases》 34 (1–2): 140–6. doi:10.1159/000443129. PMC 4820247. PMID 26981630.
Tsang-A-Sjoe MW, Bultink IE (2015). “Systemic lupus erythematosus: review of synthetic drugs”. 《Expert Opinion on Pharmacotherapy》 16 (18): 2793–806. doi:10.1517/14656566.2015.1101448. PMID 26479437. S2CID 36049926. ] To date, three small [86–88] RCTs in SLE patients have been published, including in total 76 patients in the active arm
Mol F, Mol BW, Ankum WM, van der Veen F, Hajenius PJ (2008). “Current evidence on surgery, systemic methotrexate and expectant management in the treatment of tubal ectopic pregnancy: a systematic review and meta-analysis”. 《Human Reproduction Update》 14 (4): 309–19. doi:10.1093/humupd/dmn012. PMID 18522946.
Oliff A, Bleyer WA, Poplack DG (1979년 9월 1일). “Methotrexate-induced oral mucositis and salivary methotrexate concentrations”. 《Cancer Chemotherapy and Pharmacology》 2 (3): 225–226. doi:10.1007/BF00258300. PMID 313282. S2CID 6273303.
Fragoulis GE, Nikiphorou E, Larsen J, Korsten P, Conway R (2019). “Methotrexate-Associated Pneumonitis and Rheumatoid Arthritis-Interstitial Lung Disease: Current Concepts for the Diagnosis and Treatment”. 《Frontiers in Medicine》 6: 238. doi:10.3389/fmed.2019.00238. PMC 6819370. PMID 31709258.
Russell MD, Dey M, Flint J, Davie P, Allen A, Crossley A 외 (BSR Standards, Audit and Guidelines Working Group) (November 2022). “Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids”. 《Rheumatology》 62 (4): 1370–1387. doi:10.1093/rheumatology/keac558. PMC 10070067. PMID 36318965.
Scheinfeld N (December 2006). “Three cases of toxic skin eruptions associated with methotrexate and a compilation of methotrexate-induced skin eruptions”. 《Dermatology Online Journal》 12 (7): 15. doi:10.5070/D30NQ2C0BX. PMID 17459301.
Hafner DL (August 2009). “Lost in the fog: understanding "chemo brain"”. 《Nursing》 39 (8): 42–5. doi:10.1097/01.nurse.0000358574.56241.2f. PMID 19633502. S2CID 9456346.
Rajagopalan PT, Zhang Z, McCourt L, Dwyer M, Benkovic SJ, Hammes GG (October 2002). “Interaction of dihydrofolate reductase with methotrexate: ensemble and single-molecule kinetics”. 《Proceedings of the National Academy of Sciences of the United States of America》 99 (21): 13481–6. Bibcode:2002PNAS...9913481R. doi:10.1073/pnas.172501499. PMC 129699. PMID 12359872.
Goodsell DS (August 1999). “The molecular perspective: methotrexate”. 《The Oncologist》 4 (4): 340–1. doi:10.1634/theoncologist.4-4-340. PMID 10476546. 2012년 5월 24일에 원본 문서에서 보존된 문서. 2023년 10월 8일에 확인함.
Wessels JA, Huizinga TW, Guchelaar HJ (March 2008). “Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis”. 《Rheumatology》 47 (3): 249–55. doi:10.1093/rheumatology/kem279. PMID 18045808.
Böhm I (June 2004). “Increased peripheral blood B-cells expressing the CD5 molecules in association to autoantibodies in patients with lupus erythematosus and evidence to selectively down-modulate them”. 《Biomedicine & Pharmacotherapy》 58 (5): 338–43. doi:10.1016/j.biopha.2004.04.010. PMID 15194170.
Brody M, Böhm I, Bauer R (October 1993). “Mechanism of action of methotrexate: experimental evidence that methotrexate blocks the binding of interleukin 1 beta to the interleukin 1 receptor on target cells”. 《European Journal of Clinical Chemistry and Clinical Biochemistry》 31 (10): 667–74. CiteSeerX 10.1.1.633.8921. doi:10.1515/cclm.1993.31.10.667. PMID 8292668. S2CID 25311594.
Meyer LM, Miller FR, Rowen MJ, Bock G, Rutzky J (September 1950). “Treatment of acute leukemia with amethopterin (4-amino, 10-methyl pteroyl glutamic acid)”. 《Acta Haematologica》 4 (3): 157–67. doi:10.1159/000203749. PMID 14777272.
Hertz R, Li MC, Spencer DB (November 1956). “Effect of methotrexate therapy upon choriocarcinoma and chorioadenoma”. 《Proceedings of the Society for Experimental Biology and Medicine》 93 (2): 361–6. doi:10.3181/00379727-93-22757. PMID 13379512. S2CID 22939197.
Wright JC, Lyons MM, Walker DG, Golomb FM, Gumport SL, Medrek TJ (August 1964). “Observations on the Use of Cancer Chemotherapeutic Agents in Patients With Mycosis Fungoides”. 《Cancer》 17 (8): 1045–62. doi:10.1002/1097-0142(196408)17:8<1045::AID-CNCR2820170811>3.0.CO;2-S. PMID 14202592.

drugs.com (Global: 529^th place; Korean: 121^st place)

“Methotrexate”. 《The American Society of Health-System Pharmacists》. 2016년 10월 8일에 원본 문서에서 보존된 문서. 22 Aug 2016에 확인함.

economist.com (Global: 331^st place; Korean: 242^nd place)

“Today's anti-cancer tools are ever better wielded”. 《이코노미스트》. 2017년 9월 14일. 2017년 9월 16일에 확인함.

hu-berlin.de (Global: 3,223^rd place; Korean: 2,866^th place)

edoc.hu-berlin.de

Boehm IB, Boehm GA, Bauer R (1998). “Management of cutaneous lupus erythematosus with low-dose methotrexate: indication for modulation of inflammatory mechanisms”. 《Rheumatol Int》 18 (2): 59–62. doi:10.1515/cclm.1993.31.10.667. PMID 9782534. S2CID 25311594.

mayoclinic.org (Global: 2,191^st place; Korean: 636^th place)

“Medical abortion - Mayo Clinic” (영어). 《www.mayoclinic.org》. 2022년 7월 10일에 확인함.

medicines.org.uk (Global: 4,892^nd place; Korean: 1,205^th place)

“Methotrexate 2.5 mg Tablets - Summary of Product Characteristics (SmPC) - (emc)”. 《www.medicines.org.uk》. 2023년 2월 19일에 확인함.

medicinescomplete.com (Global: low place; Korean: 3,115^th place)

Brayfield A 편집 (2014년 1월 6일). “Methotrexate”. 《Martindale: The Complete Drug Reference》. Pharmaceutical Press. 2014년 4월 12일에 확인함.

medscape.com (Global: 1,078^th place; Korean: 351^st place)

reference.medscape.com

“Trexall, Rheumatrex (methotrexate) dosing, indications, interactions, adverse effects, and more”. 《Medscape Reference》. WebMD. 8 February 2014에 원본 문서에서 보존된 문서. 12 April 2014에 확인함.

mshpriceguide.org (Global: low place; Korean: 2,198^th place)

“Methotrexate Sodium”. 《International Drug Price Indicator Guide》. 2019년 6월 11일에 원본 문서에서 보존된 문서. 2016년 8월 23일에 확인함.

nice.org.uk (Global: 4,081^st place; Korean: 1,265^th place)

“BNF is only available in the UK”. 《NICE》. 2023년 2월 19일에 확인함.

nih.gov (Global: 5^th place; Korean: 4^th place)

ncbi.nlm.nih.gov

Bannwarth, B; Labat, L; Moride, Y; Schaeverbeke, T (January 1994). “Methotrexate in rheumatoid arthritis. An update.”. 《Drugs》 47 (1): 25–50. doi:10.2165/00003495-199447010-00003. PMID 7510620.
Herfarth HH, Long MD, Isaacs KL (2012). “Methotrexate: underused and ignored?”. 《Digestive Diseases》 30 (Suppl 3): 112–8. doi:10.1159/000342735. PMC 4629813. PMID 23295701.
Boehm IB, Boehm GA, Bauer R (1998). “Management of cutaneous lupus erythematosus with low-dose methotrexate: indication for modulation of inflammatory mechanisms”. 《Rheumatol Int》 18 (2): 59–62. doi:10.1515/cclm.1993.31.10.667. PMID 9782534. S2CID 25311594.
Lopez-Olivo MA, Siddhanamatha HR, Shea B, Tugwell P, Wells GA, Suarez-Almazor ME (June 2014). “Methotrexate for treating rheumatoid arthritis”. 《The Cochrane Database of Systematic Reviews》 2014 (6): CD000957. doi:10.1002/14651858.CD000957.pub2. PMC 7047041. PMID 24916606.
Cronstein BN (June 2005). “Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis”. 《Pharmacological Reviews》 57 (2): 163–72. doi:10.1124/pr.57.2.3. PMID 15914465. S2CID 1643606.
American Rheumatoid Arthritis Guidelines (February 2002). “Guidelines for the management of rheumatoid arthritis: 2002 Update”. 《Arthritis and Rheumatism》 46 (2): 328–46. doi:10.1002/art.10148. PMID 11840435.
Colebatch AN, Marks JL, Edwards CJ (November 2011). “Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis)”. 《The Cochrane Database of Systematic Reviews》 (11): CD008872. doi:10.1002/14651858.CD008872.pub2. PMID 22071858.
Donahue KE, Schulman ER, Gartlehner G, Jonas BL, Coker-Schwimmer E, Patel SV 외 (October 2019). “Comparative Effectiveness of Combining MTX with Biologic Drug Therapy Versus Either MTX or Biologics Alone for Early Rheumatoid Arthritis in Adults: a Systematic Review and Network Meta-analysis”. 《Journal of General Internal Medicine》 34 (10): 2232–2245. doi:10.1007/s11606-019-05230-0. PMC 6816735. PMID 31388915.
Herfarth HH (2016년 1월 1일). “Methotrexate for Inflammatory Bowel Diseases - New Developments”. 《Digestive Diseases》 34 (1–2): 140–6. doi:10.1159/000443129. PMC 4820247. PMID 26981630.
Tsang-A-Sjoe MW, Bultink IE (2015). “Systemic lupus erythematosus: review of synthetic drugs”. 《Expert Opinion on Pharmacotherapy》 16 (18): 2793–806. doi:10.1517/14656566.2015.1101448. PMID 26479437. S2CID 36049926. ] To date, three small [86–88] RCTs in SLE patients have been published, including in total 76 patients in the active arm
Mol F, Mol BW, Ankum WM, van der Veen F, Hajenius PJ (2008). “Current evidence on surgery, systemic methotrexate and expectant management in the treatment of tubal ectopic pregnancy: a systematic review and meta-analysis”. 《Human Reproduction Update》 14 (4): 309–19. doi:10.1093/humupd/dmn012. PMID 18522946.
Oliff A, Bleyer WA, Poplack DG (1979년 9월 1일). “Methotrexate-induced oral mucositis and salivary methotrexate concentrations”. 《Cancer Chemotherapy and Pharmacology》 2 (3): 225–226. doi:10.1007/BF00258300. PMID 313282. S2CID 6273303.
Fragoulis GE, Nikiphorou E, Larsen J, Korsten P, Conway R (2019). “Methotrexate-Associated Pneumonitis and Rheumatoid Arthritis-Interstitial Lung Disease: Current Concepts for the Diagnosis and Treatment”. 《Frontiers in Medicine》 6: 238. doi:10.3389/fmed.2019.00238. PMC 6819370. PMID 31709258.
Gromnica-Ihle E, Krüger K (2010년 9월 1일). “Use of methotrexate in young patients with respect to the reproductive system”. 《Clinical and Experimental Rheumatology》 28 (5 Suppl 61): S80–4. PMID 21044438.
Russell MD, Dey M, Flint J, Davie P, Allen A, Crossley A 외 (BSR Standards, Audit and Guidelines Working Group) (November 2022). “Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids”. 《Rheumatology》 62 (4): 1370–1387. doi:10.1093/rheumatology/keac558. PMC 10070067. PMID 36318965.
Scheinfeld N (December 2006). “Three cases of toxic skin eruptions associated with methotrexate and a compilation of methotrexate-induced skin eruptions”. 《Dermatology Online Journal》 12 (7): 15. doi:10.5070/D30NQ2C0BX. PMID 17459301.
Hafner DL (August 2009). “Lost in the fog: understanding "chemo brain"”. 《Nursing》 39 (8): 42–5. doi:10.1097/01.nurse.0000358574.56241.2f. PMID 19633502. S2CID 9456346.
Rajagopalan PT, Zhang Z, McCourt L, Dwyer M, Benkovic SJ, Hammes GG (October 2002). “Interaction of dihydrofolate reductase with methotrexate: ensemble and single-molecule kinetics”. 《Proceedings of the National Academy of Sciences of the United States of America》 99 (21): 13481–6. Bibcode:2002PNAS...9913481R. doi:10.1073/pnas.172501499. PMC 129699. PMID 12359872.
Goodsell DS (August 1999). “The molecular perspective: methotrexate”. 《The Oncologist》 4 (4): 340–1. doi:10.1634/theoncologist.4-4-340. PMID 10476546. 2012년 5월 24일에 원본 문서에서 보존된 문서. 2023년 10월 8일에 확인함.
Wessels JA, Huizinga TW, Guchelaar HJ (March 2008). “Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis”. 《Rheumatology》 47 (3): 249–55. doi:10.1093/rheumatology/kem279. PMID 18045808.
Böhm I (June 2004). “Increased peripheral blood B-cells expressing the CD5 molecules in association to autoantibodies in patients with lupus erythematosus and evidence to selectively down-modulate them”. 《Biomedicine & Pharmacotherapy》 58 (5): 338–43. doi:10.1016/j.biopha.2004.04.010. PMID 15194170.
Brody M, Böhm I, Bauer R (October 1993). “Mechanism of action of methotrexate: experimental evidence that methotrexate blocks the binding of interleukin 1 beta to the interleukin 1 receptor on target cells”. 《European Journal of Clinical Chemistry and Clinical Biochemistry》 31 (10): 667–74. CiteSeerX 10.1.1.633.8921. doi:10.1515/cclm.1993.31.10.667. PMID 8292668. S2CID 25311594.
Meyer LM, Miller FR, Rowen MJ, Bock G, Rutzky J (September 1950). “Treatment of acute leukemia with amethopterin (4-amino, 10-methyl pteroyl glutamic acid)”. 《Acta Haematologica》 4 (3): 157–67. doi:10.1159/000203749. PMID 14777272.
Wright JC, Prigot A, Wright B, Weintraub S, Wright LT (July 1951). “An evaluation of folic acid antagonists in adults with neoplastic diseases: a study of 93 patients with incurable neoplasms”. 《Journal of the National Medical Association》 43 (4): 211–40. PMC 2616951. PMID 14850976.
Hertz R, Li MC, Spencer DB (November 1956). “Effect of methotrexate therapy upon choriocarcinoma and chorioadenoma”. 《Proceedings of the Society for Experimental Biology and Medicine》 93 (2): 361–6. doi:10.3181/00379727-93-22757. PMID 13379512. S2CID 22939197.
Wright JC, Gumport SL, Golomb FM (November 1960). “Remissions produced with the use of Methotrexate in patients with mycosis fungoides”. 《Cancer Chemotherapy Reports》 9: 11–20. PMID 13786791.
Wright JC, Lyons MM, Walker DG, Golomb FM, Gumport SL, Medrek TJ (August 1964). “Observations on the Use of Cancer Chemotherapeutic Agents in Patients With Mycosis Fungoides”. 《Cancer》 17 (8): 1045–62. doi:10.1002/1097-0142(196408)17:8<1045::AID-CNCR2820170811>3.0.CO;2-S. PMID 14202592.

nras.org.uk (Global: low place; Korean: low place)

“Methotrexate and its use in rheumatoid arthritis (RA)” (영국 영어). 《NRAS》. 2023년 2월 19일에 확인함.

psu.edu (Global: 299^th place; Korean: 150^th place)

citeseerx.ist.psu.edu

Brody M, Böhm I, Bauer R (October 1993). “Mechanism of action of methotrexate: experimental evidence that methotrexate blocks the binding of interleukin 1 beta to the interleukin 1 receptor on target cells”. 《European Journal of Clinical Chemistry and Clinical Biochemistry》 31 (10): 667–74. CiteSeerX 10.1.1.633.8921. doi:10.1515/cclm.1993.31.10.667. PMID 8292668. S2CID 25311594.

semanticscholar.org (Global: 15^th place; Korean: 11^th place)

api.semanticscholar.org

Boehm IB, Boehm GA, Bauer R (1998). “Management of cutaneous lupus erythematosus with low-dose methotrexate: indication for modulation of inflammatory mechanisms”. 《Rheumatol Int》 18 (2): 59–62. doi:10.1515/cclm.1993.31.10.667. PMID 9782534. S2CID 25311594.
Cronstein BN (June 2005). “Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis”. 《Pharmacological Reviews》 57 (2): 163–72. doi:10.1124/pr.57.2.3. PMID 15914465. S2CID 1643606.
Tsang-A-Sjoe MW, Bultink IE (2015). “Systemic lupus erythematosus: review of synthetic drugs”. 《Expert Opinion on Pharmacotherapy》 16 (18): 2793–806. doi:10.1517/14656566.2015.1101448. PMID 26479437. S2CID 36049926. ] To date, three small [86–88] RCTs in SLE patients have been published, including in total 76 patients in the active arm
Oliff A, Bleyer WA, Poplack DG (1979년 9월 1일). “Methotrexate-induced oral mucositis and salivary methotrexate concentrations”. 《Cancer Chemotherapy and Pharmacology》 2 (3): 225–226. doi:10.1007/BF00258300. PMID 313282. S2CID 6273303.
Hafner DL (August 2009). “Lost in the fog: understanding "chemo brain"”. 《Nursing》 39 (8): 42–5. doi:10.1097/01.nurse.0000358574.56241.2f. PMID 19633502. S2CID 9456346.
Brody M, Böhm I, Bauer R (October 1993). “Mechanism of action of methotrexate: experimental evidence that methotrexate blocks the binding of interleukin 1 beta to the interleukin 1 receptor on target cells”. 《European Journal of Clinical Chemistry and Clinical Biochemistry》 31 (10): 667–74. CiteSeerX 10.1.1.633.8921. doi:10.1515/cclm.1993.31.10.667. PMID 8292668. S2CID 25311594.
Hertz R, Li MC, Spencer DB (November 1956). “Effect of methotrexate therapy upon choriocarcinoma and chorioadenoma”. 《Proceedings of the Society for Experimental Biology and Medicine》 93 (2): 361–6. doi:10.3181/00379727-93-22757. PMID 13379512. S2CID 22939197.

semanticscholar.org

Cronstein BN (June 2005). “Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis”. 《Pharmacological Reviews》 57 (2): 163–72. doi:10.1124/pr.57.2.3. PMID 15914465. S2CID 1643606.

versusarthritis.org (Global: low place; Korean: low place)

“Methotrexate” (영국 영어). 《Versus Arthritis》. 2023년 2월 19일에 원본 문서에서 보존된 문서. 2023년 2월 19일에 확인함.

web.archive.org (Global: 1^st place; Korean: 1^st place)

“Trexall, Rheumatrex (methotrexate) dosing, indications, interactions, adverse effects, and more”. 《Medscape Reference》. WebMD. 8 February 2014에 원본 문서에서 보존된 문서. 12 April 2014에 확인함.
“Methotrexate”. 《The American Society of Health-System Pharmacists》. 2016년 10월 8일에 원본 문서에서 보존된 문서. 22 Aug 2016에 확인함.
Sneader, Walter (2005). 《Drug Discovery: A History》 (영어). John Wiley & Sons. 251쪽. ISBN 9780470015520. 2017년 2월 16일에 원본 문서에서 보존된 문서.
“WHO Model List of Essential Medicines (19th List)” (PDF). 《World Health Organization》. April 2015. 13 December 2016에 원본 문서 (PDF)에서 보존된 문서. 8 December 2016에 확인함.
“Methotrexate Sodium”. 《International Drug Price Indicator Guide》. 2019년 6월 11일에 원본 문서에서 보존된 문서. 2016년 8월 23일에 확인함.
“Methotrexate” (영국 영어). 《Versus Arthritis》. 2023년 2월 19일에 원본 문서에서 보존된 문서. 2023년 2월 19일에 확인함.
Goodsell DS (August 1999). “The molecular perspective: methotrexate”. 《The Oncologist》 4 (4): 340–1. doi:10.1634/theoncologist.4-4-340. PMID 10476546. 2012년 5월 24일에 원본 문서에서 보존된 문서. 2023년 10월 8일에 확인함.

who.int (Global: 213^th place; Korean: 111^th place)

“WHO Model List of Essential Medicines (19th List)” (PDF). 《World Health Organization》. April 2015. 13 December 2016에 원본 문서 (PDF)에서 보존된 문서. 8 December 2016에 확인함.

메토트렉세이트 (Korean Wikipedia)

adsabs.harvard.edu (Global: 14th place; Korean: 8th place)

alphamedpress.org (Global: low place; Korean: low place)

theoncologist.alphamedpress.org

archive.org (Global: 6th place; Korean: 5th place)

books.google.com (Global: 3rd place; Korean: 7th place)

clincalc.com (Global: 5,833rd place; Korean: 1,335th place)

doi.org (Global: 2nd place; Korean: 3rd place)

dx.doi.org

drugs.com (Global: 529th place; Korean: 121st place)

economist.com (Global: 331st place; Korean: 242nd place)

hu-berlin.de (Global: 3,223rd place; Korean: 2,866th place)

edoc.hu-berlin.de

mayoclinic.org (Global: 2,191st place; Korean: 636th place)

medicines.org.uk (Global: 4,892nd place; Korean: 1,205th place)

medicinescomplete.com (Global: low place; Korean: 3,115th place)

medscape.com (Global: 1,078th place; Korean: 351st place)

reference.medscape.com

mshpriceguide.org (Global: low place; Korean: 2,198th place)

nice.org.uk (Global: 4,081st place; Korean: 1,265th place)

nih.gov (Global: 5th place; Korean: 4th place)

ncbi.nlm.nih.gov

nras.org.uk (Global: low place; Korean: low place)

psu.edu (Global: 299th place; Korean: 150th place)

citeseerx.ist.psu.edu

semanticscholar.org (Global: 15th place; Korean: 11th place)

api.semanticscholar.org

semanticscholar.org

versusarthritis.org (Global: low place; Korean: low place)

web.archive.org (Global: 1st place; Korean: 1st place)

who.int (Global: 213th place; Korean: 111th place)

adsabs.harvard.edu (Global: 14^th place; Korean: 8^th place)

archive.org (Global: 6^th place; Korean: 5^th place)

books.google.com (Global: 3^rd place; Korean: 7^th place)

clincalc.com (Global: 5,833^rd place; Korean: 1,335^th place)

doi.org (Global: 2^nd place; Korean: 3^rd place)

drugs.com (Global: 529^th place; Korean: 121^st place)

economist.com (Global: 331^st place; Korean: 242^nd place)

hu-berlin.de (Global: 3,223^rd place; Korean: 2,866^th place)

mayoclinic.org (Global: 2,191^st place; Korean: 636^th place)

medicines.org.uk (Global: 4,892^nd place; Korean: 1,205^th place)

medicinescomplete.com (Global: low place; Korean: 3,115^th place)

medscape.com (Global: 1,078^th place; Korean: 351^st place)

mshpriceguide.org (Global: low place; Korean: 2,198^th place)

nice.org.uk (Global: 4,081^st place; Korean: 1,265^th place)

nih.gov (Global: 5^th place; Korean: 4^th place)

psu.edu (Global: 299^th place; Korean: 150^th place)

semanticscholar.org (Global: 15^th place; Korean: 11^th place)

web.archive.org (Global: 1^st place; Korean: 1^st place)

who.int (Global: 213^th place; Korean: 111^th place)